TY - JOUR
T1 - Sexual side effects from treatment with SSRI
AU - Hutters, Cecilie Lybeck
AU - Giraldi, Annamaria
PY - 2022/4/4
Y1 - 2022/4/4
N2 - Treatment with SSRI have a high frequency of treatment of emergent sexual dysfunction. The mechanism is thought to be through serotoninergic inhibition of the sexual response. More than 70% of patients treated with sertraline, citalopram or paroxetine experience sexual side effects, while escitalopram and fluvoxamine yield the lowest degree of sexual dysfunction within the group. This review suggests management strategies including dose reduction, change of medication and add-on treatment. A small group of patients experience post-SSRI dysfunction, in which sexual dysfunction persists after treatment termination.
AB - Treatment with SSRI have a high frequency of treatment of emergent sexual dysfunction. The mechanism is thought to be through serotoninergic inhibition of the sexual response. More than 70% of patients treated with sertraline, citalopram or paroxetine experience sexual side effects, while escitalopram and fluvoxamine yield the lowest degree of sexual dysfunction within the group. This review suggests management strategies including dose reduction, change of medication and add-on treatment. A small group of patients experience post-SSRI dysfunction, in which sexual dysfunction persists after treatment termination.
KW - Citalopram/adverse effects
KW - Humans
KW - Paroxetine/adverse effects
KW - Serotonin Uptake Inhibitors/adverse effects
KW - Sertraline/adverse effects
KW - Sexual Dysfunction, Physiological/chemically induced
UR - http://www.scopus.com/inward/record.url?scp=85128065623&partnerID=8YFLogxK
M3 - Review
C2 - 35410653
SN - 0041-5782
VL - 184
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 14
M1 - V11210824
ER -